Skip navigation
|
Home
Contact us
Urdu
Confidential Helpline
0845 223 4424
[
Viewing options
]
Search
Hepatitis C Info
Treatment
Living with Hep C
Support
Get Involved
News & Resources
The Trust
News
Media centre
Resources
Trust Updates
Glossary
Community Links
News
2012
2011
2010
2009
2008
December
November
October
September
August
July
June
Vertex announces new trial of telaprevir in non responders
Vertex CEO preparing for 09 hepatitis drug launch
Very Early Response to Interferon-based Therapy for Hepatitis C Is Apparent within the First 24 Hours
Course of Chronic Hepatitis C in Children
Central Asia: World Bank Warns Of Tainted Blood Transfusions Across Region
Poly-MVA - The First Dietary Supplement To Be Cleared By The FDA For Use In A Cancer Study
For Patients with HCV Genotype 6 - 48 Weeks Treatment is Superior to 24 Weeks
Active and Recovering Injection Drug Users Can Benefit from Hepatitis C Treatment if They Maintain Good Adherence
Will Vertex seek regulatory approval for telaprevir in 2009?
Vertex reports on Prove 3 interim results
Herbal Product Stevioside Inhibits HCV Replication and Curcumin Suppresses Fibrogenic Cell Activity in Laboratory Studies
Last public hearing of independent public inquiry into Contaminated Blood and Blood Products
Selective hepatitis C screening for pregnant women isn't working
Tattoed Irish Should Be Tested for Hepatitis C
Mortality Due to Hepatitis C in the U.S.: Has the Worst Passed?
Eltrombopag Trial Results
Parliamentary Debate on Liver Disease
May
April
March
February
January
World Hepatitis Day News
News From AASLD Liver Conference 2008
2007
2006
2005
2004
Home
>
News & Resources
>
News
>
2008
>
June
>
Parliamentary Debate on Liver Disease
Parliamentary Debate on Liver Disease
Westminster Hall debates
Wednesday, 21 May 2008 - Liver Disease
Click Here
to read this debate
Print this page
Email to a friend
Share
Hepatitis Info
About hep C
Just diagnosed?
Risk factors
Stages of hep C
Considering a test
Symptoms
Cirrhosis
Treatment
Considering
Choosing
Side effects
Preparing for treatment
New drugs
Interferon and ribavirin
Living with
Caring for yourself
Prevention
Mental and emotional
Alternative Medicine
Doctors and Consultants
Support
Support Groups
The importance of support
Helpline
Advocacy
Skipton fund
News & Resources
Resources
Newsletter
Media centre
Get Involved
Volunteering
Fundraising
Campaigning
Become a member
Get tested!
World hepatitis day
Personal stories
About us
Contact us
The team
The work we do
Donate
Resources
Media
About the Trust
[
Sign In
]
[
Sign Up
]